Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid and Coronary Explorations, Compared to Simple Risk Calculation Using the European "SCORE 2" Algorithm. (IDEA-CVR)
This clinical trial evaluates a strategy using carotid and coronary imaging to identify asymptomatic individuals at very high cardiovascular…
-
EMA approval · 2025-11-27EMA Authorised: Metalyse (tenecteplase) — Boehringer Ingelheim International GmbH
The European Medicines Agency authorised Metalyse (tenecteplase) by Boehringer Ingelheim International GmbH for the treatment of myocardial …
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction
An update on a Zhejiang University clinical trial developing an enhanced prediction model to forecast major adverse events after acute myoca…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance [NA]
This clinical trial update discusses a pilot study evaluating four different consent approaches to increase attendance at cardiac rehabilita…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects [Phase 1]
Phase 1 trial evaluating safety and tolerability of SGC001 in healthy subjects; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergoing Phase II Cardiac Rehabilitation. [NA]
A pilot randomized controlled trial compares core exercise, aerobic exercise, and combined exercise regimens in patients undergoing Phase II…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Clinical Profile of a Patient After MI and ACVA Based on Outpatient Register Data
A clinical trial update describes the clinical profile of a patient who has experienced myocardial infarction and acute cerebrovascular acci…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients [Phase 4]
Phase 4 trial evaluating initiation of a PCSK9 inhibitor before percutaneous coronary intervention in acute myocardial infarction patients; …
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) [NA]
Completed clinical study evaluating a mobile case management approach to improve cardiac rehabilitation outcomes. The trial targeted patient…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT) [NA]
This clinical trial, EPISODE VT, recruits to compare epicardial plus endocardial catheter ablation versus endocardial-only ablation for isch…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Polyamine Treatment in Elderly Patients With Coronary Artery Disease [Phase 2]
Phase 2 clinical trial evaluating polyamine treatment in elderly patients with ischemic heart disease and myocardial infarction; currently a…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Barts-MINOCA Registry
Registry trial update for the Barts-MINOCA Registry sponsored by Queen Mary University of London; the study is currently recruiting and focu…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons
This clinical trial registry entry describes a study on outcomes after revascularization using drug-coated balloons in coronary disease and …
-
EMA approval · 2025-11-13EMA Authorised: Efient (prasugrel) — Substipharm
The EMA has authorised Efient (prasugrel) by Substipharm for indications including acute coronary syndrome, unstable angina, and myocardial …
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Clinical Evaluation of Radiation Reduction for Optimized Safety
A clinical trial to evaluate radiation reduction for safer imaging in people with coronary artery disease and myocardial infarction. The stu…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Women's Health Initiative Strong and Healthy Study [NA]
The Women's Health Initiative Strong and Healthy study has completed and reports cardiovascular and other health outcomes. It tracks events …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: GSI Cardiac on Revolution Apex - US
Clinical trial update indicating US recruitment for GE Healthcare's GSI Cardiac on the Revolution Apex system to evaluate imaging in coronar…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Multicenter Study of Silent Myocardial Ischemia (MSSMI)
This clinical trial update reports the completion of a multicenter study evaluating silent myocardial ischemia (MSSMI) sponsored by the Univ…
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (BIONPHARMA INC.)
FDA approved an original application for ticagrelor from Bionpharma Inc., making a generic version of this antiplatelet medication available…
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (Dr. Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' original application for ticagrelor as a generic version of the antiplatelet drug, expanding access t…
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (Oryza Pharmaceuticals, Inc.)
FDA approved the ticagrelor product from Oryza Pharmaceuticals, Inc. under its original application (ANDA 208508).
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (Radha Pharmaceuticals INC)
FDA approves Radha Pharmaceuticals INC's original ANDA for Ticagrelor, a generic antiplatelet medication.
-
FDA approval · 2025-10-28FDA Approved: TICAGRELOR — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an Original Application for ticagrelor from Novadoz Pharmaceuticals LLC, indicating the approval of a generic ticagrelor produc…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Evolocumab in Patients With Acute MI [Phase 2]
Phase 2 clinical trial update on evolocumab in patients with acute coronary syndrome and acute myocardial infarction; results have been post…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Telehealth-enhanced Hybrid Cardiac Rehabilitation Among Acute Coronary Syndrome Survivors [NA]
An update on a completed clinical trial evaluating telehealth-enhanced hybrid cardiac rehabilitation for acute coronary syndrome survivors, …